Literature DB >> 10925970

Prospective blinded trial of a fecal antigen test for the detection of Helicobacter pylori infection.

N Vakil1, A Affi, J Robinson, M Sundaram, S Phadnis.   

Abstract

OBJECTIVE: We prospectively studied an FDA-approved stool test for the diagnosis of Helicobacter pylori infection based on the detection of antigens shed in stool.
METHODS: We studied 108 patients undergoing endoscopy. Stool samples were collected on the day of the endoscopy and read in a blinded manner by a technician who was unaware of the findings of the endoscopy. The results of stool testing were compared to those of the rapid urease test (Pyloritek).
RESULTS: There were 51 patients infected with H. pylori by rapid urease testing and 57 who were not. The sensitivity of the stool test was 86% (95% confidence interval: 77-96%), the specificity was 91% (81-97%), with a positive predictive value of 89% (77-96%) and a negative predictive value of 88% (81-97%). The likelihood ratio for a positive test was 10.18 and the likelihood ratio for a negative test was 0.11.
CONCLUSIONS: The stool test was sensitive and specific for the detection of H. pylori in a U.S. population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925970     DOI: 10.1111/j.1572-0241.2000.02192.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  2 in total

1.  Diagnosis of Helicobacter pylori infection in adults with intellectual disability.

Authors:  Robyn A Wallace; Philip J Schluter; Ross Forgan-Smith; Robyn Wood; Penelope M Webb
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 2.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.